Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$190.52 - $236.72 $2,286 - $2,840
12 New
12 $2,000
Q4 2020

Jan 19, 2021

SELL
$236.26 - $355.63 $5,670 - $8,535
-24 Closed
0 $0
Q3 2020

Oct 19, 2020

BUY
$264.77 - $305.71 $6,354 - $7,337
24 New
24 $7,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track First Command Advisory Services, Inc. Portfolio

Follow First Command Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Advisory Services, Inc. with notifications on news.